Doctor Summary

Laurence Mercer fictional · synthetic demo record

Prepared in Medical Records Interlinked (MRI) from 7 source documents · latest source dated 12 Mar 2026

A concise, evidence-linked view of the documented history held in this record. Every statement links to its source; statements marked “Calculated” describe relationships computed from the record rather than wording stated in a document.

Current documented picture

10 documented measurements across 5 analytes. 1 treatment documented · latest status: Oral iron · Prescribed.

Laboratory measurements

  • Ferritin: latest documented date 27 Jan 2026; 2 results in this record.
  • Ferritin — 19.6 μg/L · 27 Jan 2026 · supplied range 15–150 μg/L.
  • TSH: latest documented date 27 Jan 2026; 2 results in this record.
  • TSH — 3.2 mIU/L · 27 Jan 2026 · supplied range 0.4–4 mIU/L.
  • Vitamin D (25-OH): latest documented date 27 Jan 2026; 2 results in this record.
  • Vitamin D (25-OH) — 24 ng/mL · 27 Jan 2026 · supplied range 30–100 ng/mL.
  • C-reactive protein: latest documented date 27 Jan 2026; 2 results in this record.
  • C-reactive protein — 3.1 mg/L · 27 Jan 2026 · supplied range 0–5 mg/L.
  • Creatinine: latest documented date 27 Jan 2026; 2 results in this record.
  • Creatinine — 0.92 mg/dL · 27 Jan 2026 · supplied range 0.6–1.2 mg/dL.

Medication statements

  • Oral iron (ferrous sulfate) — Prescribed · documented 3 Feb 2026.

Imaging

  • Thyroid ultrasound · 10 Sep 2025. A well-defined 9 mm nodule is seen in the right lobe.
  • Thyroid ultrasound · 12 Mar 2026. The right lobe nodule measures 9 mm, unchanged in size compared with the previous examination.

Documented recommendations

  • 10 Sep 2025: “Follow-up ultrasound in 6 months is recommended.”
  • 3 Feb 2026: “Repeat ferritin in 3 months.”
  • 12 Mar 2026: “Follow-up ultrasound in 12 months is recommended.”

Documented incident

  • Anaphylaxis occurred after amoxicillin. Epinephrine was administered in the emergency department.
  • Incident date 18 Aug 2025 · document date 19 Aug 2025.